ORIOLUSBIO Trademark

Trademark Overview

On Tuesday, May 24, 2022, a trademark application was filed for ORIOLUSBIO with the United States Patent and Trademark Office. The USPTO has given the ORIOLUSBIO trademark a serial number of 79343985. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 20, 2023. This trademark is owned by BioSenic, Naamloze vennootschap. The ORIOLUSBIO trademark is filed in the Pharmaceutical Products category with the following description:

Cell, gene and protein-based therapy products for treating and preventing musculoskeletal indications and inflammatory related diseases
oriolusbio

General Information

Serial Number79343985
Word MarkORIOLUSBIO
Filing DateTuesday, May 24, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCell, gene and protein-based therapy products for treating and preventing musculoskeletal indications and inflammatory related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioSenic, Naamloze vennootschap
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Thursday, June 30, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 5, 2022APPLICATION FILING RECEIPT MAILED
Saturday, March 4, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 13, 2023ASSIGNED TO EXAMINER
Tuesday, March 14, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 15, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 3, 2023REFUSAL PROCESSED BY MPU
Wednesday, May 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 24, 2023REFUSAL PROCESSED BY IB
Monday, November 20, 2023ASSIGNED TO EXAMINER
Monday, November 20, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 20, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, November 20, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, December 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, June 22, 2024NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 21, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, December 7, 2024FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

oriolusbio indications musculoskeletal inflammatory related diseases preventing treating protein gene based